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Abstract
Aims/hypothesis Upregulation of the functional beta cell
mass is required to match the physiological demands of
mother and fetus during pregnancy. This increase is
dependent on placental lactogens (PLs) and prolactin
receptors, but the mechanisms underlying these events are
only partially understood. We studied the mRNA expres-
sion profile of mouse islets during pregnancy to gain a
better insight into these changes.
Methods RNA expression was measured ex vivo via
microarrays and quantitative RT-PCR. In vivo observations
were extended by in vitro models in which ovine PL was
added to cultured mouse islets and MIN6 cells.
Results mRNA encoding both isoforms of the rate-
limiting enzyme of serotonin biosynthesis, tryptophan
hydroxylase (TPH), i.e. Tph1 and Tph2,w e r es t r o n g l y
induced (fold change 25- to 200-fold) during pregnancy.
This induction was mimicked by exposing islets or MIN6
cells to ovine PLs for 24 h and was dependent on janus
kinase 2 and signal transducer and activator of transcrip-
tion 5. Parallel to Tph1 mRNA and protein induction, islet
serotonin content increased to a peak level that was 200-
fold higher than basal. Interestingly, only a subpopulation
of the beta cells was serotonin-positive in vitro and in
vivo. The stored serotonin pool in pregnant islets and PL-
treated MIN6 cells was rapidly released (turnover once
every 2 h).
Conclusions/interpretation A very strong lactogen-dependent
upregulation of serotonin biosynthesis occurs in a subpopu-
lation of mouse islet beta cells during pregnancy. Since the
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Introduction
During pregnancy, more insulin is needed to support
growth and energy homeostasis of mother and fetus [1].
To meet this enhanced metabolic demand, the functional
beta cell mass is increased [2, 3]. Flexibility of the
functional beta cell mass is mediated by lactogenic
hormones, prolactin and placental lactogen (PL) [2], which
bind to prolactin receptors (PRLRs), leading to activation of
the janus kinase 2 (JAK2)–signal transducer and activator
of transcription 5 (STAT5) pathway [4, 5]. In addition to
this pathway, PRLRs can also transduce their signal via the
RAS–RAF–mitogen-activated protein kinase (MAPK) and
phosphatidylinositol 3-kinase (PI3K) pathways [6]. The
exact gene network responsible for the adaptations of islets
to pregnancy is not fully known. A recent study showed
that the expression of a large number of genes was altered
during pregnancy, including the two genes encoding
tryptophan hydroxylases (TPH) [7]. Serotonin is a mono-
amine known to control processes in the brain and
gastrointestinal tract [8, 9]. More and more studies have
indicated that serotonin influences growth and differentia-
tion of tissues [10] such as the mammary gland [11], the
nervous system [12], bone [13] and liver [14]. Serotonin is
synthesised from tryptophan via a two-step pathway
(Electronic supplementary material [ESM] Fig. 1a) [15].
The first and flux-generating step consists of hydroxylation
of tryptophan to 5-hydroxytryptophan, which is catalysed
by TPH. Two non-allelic isoforms of this enzyme exist: the
non-neuronal TPH1 and the neuronal TPH2 [16, 17]; their
production pattern is non-overlapping, with TPH1 being
produced in the pineal gland and the enterochromaffin cells,
while TPH2 is present in the neurons of the raphe nuclei
and the enteric nervous system [9, 18]. Around 95% of the
body’s serotonin is produced by enterochromaffin cells [9].
Overflow of gut serotonin is taken up and concentrated in
platelets, where it participates in platelet aggregation and
vasoconstriction [15]. Since circulating serotonin cannot
cross the blood–brain barrier, local production is required.
The last step of serotonin biosynthesis is catalysed by dopa
decarboxylase, which is abundantly expressed in beta cells
[19]. Serotonin exerts its effect via a large family of
receptors [20]. In addition, recent evidence suggests that
cytosolic serotonin regulates exocytosis in thrombocytes
[21] and in pancreatic beta cells [22] by serotonylation, a
newly identified post-translational modification.
Because of the great interest in serotonin biology and the
important change in mRNA expression of Tph genes in islets
ofpregnantmice[7], we measured serotonin biosynthesis and
release in islets of pregnant females. We also investigated the
role of PLs in the upregulation of Tph gene expression.
Methods
Preparation of islets and tissues All experiments with
laboratory animals were approved by the committee for
animal welfare at the Katholieke Universiteit Leuven. Islets
of Langerhans from C57BL6/J (Janvier, Le Genest-Saint-
Isle, France) female mice were collagenase-isolated as
previously described [23]. Other tissues were dissected
from 10- to 12-week-old C57Bl6/J (Janvier) mice. Fetal
tissue was isolated on pregnancy day (P) 15.5. Embryonic
stem cells were isolated as previously described [24].
Tissues were rinsed in PBS, frozen in liquid nitrogen and
stored at −80°C. Mouse beta cells were purified from islets
of Ripyy mice producing eYFP under the rat insulin
promoter [25].
Cellculture MIN6cells wereculturedinDMEM (Invitrogen-
Gibco, Karlsruhe, Germany) 25 mmol/l glucose equilibrated
with 5% CO2 and 95% air at 37°C and supplemented with
15% (vol./vol.) decomplemented FCS, 70 μmol/l β-
mercaptoethanol, 4 mmol/l glutamax, 50 U/ml penicillin
and 50 μg/ml streptomycin. MIN6 cells were used between
passages 20 and 30. For immunocytochemistry, MIN6 cells
were seeded on glass coverslips coated with Fibronectin-like
engineered protein polymer plus (Sigma-Aldrich, St Louis,
MO, USA) in a 12 well plate and incubated for 24 h in
DMEM (25 mmol/l glucose, 2% [vol./vol.] decomplemented
FCS, 4 mmol/l glutamax) with 0 or 500 ng/ml ovine PL
(Prospec, Rehovot, Israel). For the inhibitor experiments,
MIN6 cells were serum-starved for 24 h. Next they were pre-
2590 Diabetologia (2010) 53:2589–2599incubated for 15 to 30 min with one of the three inhibitors:
tyrphostin AG490 (50 μmol/l; Sigma-Aldrich), mitogen-
activated protein kinase kinase 1&2 (MEK1/2)-inhibitor-1
(10 μmol/l; Calbiochem-Merck Biochemicals, Darmstadt,
Germany) or wortmannin (100 nmol/l; Sigma-Aldrich).
Thereafter, they were incubated with or without 500 ng/ml
P L ,t o g e t h e rw i t hw o r t m a n n i nf o r7ho rt o g e t h e rw i t h
tyrphostin AG490 or MEK1/2-inhibitor-1 for 24 h. For
overexpression experiments, AMAXA technology (Lonza,
Cologne, Germany) was used. Briefly, using the X13
program, 5×10
6 MIN6 cells were electroporated with 2 μg
plasmid DNA and 100 μl nucleofector V (Lonza), and
recovered for 7 h in RPMI (Invitrogen-Gibco; 11 mmol/
1 glucose, 15% [vol./vol.] decomplemented FCS) medium.
Islet monolayer Extracellular matrix-coated plates and
coverslips were produced as previously described [26]. In
these coated plates, isolated islets were cultured in RPMI
medium (10% [vol./vol.] decomplemented FCS, 100 U/ml
penicillin, 100 μg/ml streptomycin, 4 mmol/l glutamax) for
7 days to form a monolayer. On day 7, islets were
stimulated with 0 or 500 ng/ml PL.
RNA extraction Total RNA from mouse islets, pure beta
cells and MIN6 cells was extracted using a kit (Absolutely
RNA microprep; Stratagene, La Jolla, CA, USA). Total RNA
was extracted from the other tissues as previously described
[27]. Total RNA quantity and quality were determined using
a spectrophotometer (ND-1000; NanoDrop Technologies,
Wilmington, DE, USA) and a bioanalyser (2100; Agilent,
Waldbronn, Germany), respectively.
mRNA expression analysis via microarray Microarray
analysis was conducted on different tissues with
MOE430-2.0 arrays (Affymetrix, Santa Clara, CA, USA)
as described [27]. To analyse the time series of pregnant
islets, total RNA (100 ng) was used to hybridise the arrays
(MoGene_1.0_ST; Affymetrix) according to manufacturer’s
manual 701880Rev4 as described previously [23]. The
different conditions were compared with each other pair-
wise on the basis of p<0.001 and a fold change of ≥1.5.
Quantitative RT-PCR Following cDNA synthesis using a
reverse transcriptase kit (RevertAid H Minus; Fermentas, St
Leon-Rot, Germany), quantitative RT-PCR (Absolute
QPCR mix; Abgene-Thermo Fisher Scientific, Waltham,
MA, USA) was performed on a Rotorgene (Corbett
Research, Mortlake, NSW, Australia) to estimate mRNA
expression of different genes. The gene encoding RNA
polymerase II (Polr2a) was used for normalisation. For
primers and probes see ESM Table 1. For Tph2 we used a
Taqman gene expression assay (Mm00557717_m1; Ap-
plied Biosystems, Carlsbad, CA, USA).
Protein levels Total protein extracts were obtained from
freshly isolated islets or MIN6 cells, which were lysed in
extraction buffer (50 mmol/l Tris, pH8; 1% [vol./vol.]
NP-40; 150 mmol/l NaCl; 1 mmol/l EDTA). Protein
extracts (100 μg for islets, 20 μgf o rM I N 6c e l l s )w e r e
separated by SDS-PAGE (10% [vol./vol.] Tris/glycine
gel; Invitrogen, Paisley, UK). The gels were blotted on
polyvinylidene fluoride membranes and, after blocking
with 4% (wt/vol.) milk, incubated with primary antibody
(ESM Table 2). Thereafter, they were incubated with
peroxidase-conjugated secondary antibody (ESM Table 2).
Detection was by ECL-system (GE Healthcare-Amersham,
Diegem, Belgium).
Immunocytochemistry After stimulation with vehicle or PL,
cells were washed with PBS and fixed with 4% (wt/vol.)
paraformaldehyde. Next cells were washed with PBS,
permeabilised with 0.2% (vol./vol.) Triton X-100 and
washed again. For TPH1 staining, the cells were immersed
in 0.1% (wt/vol.) SDS at 37°C to recover the antigen. The
cells were then washed and immersed in Hoechst solution
and thereafter washed and blocked with 5% (wt/vol.) BSA.
After blocking, primary antibodies (ESM Table 2) were
added for 1 h at room temperature in 1% (wt/vol.) BSA,
after which cells were again washed. Finally, the cells were
incubated with secondary antibodies (AlexaFluor; Invitrogen)
(ESM Table 2) for 1 h at room temperature in 1% (wt/vol.)
BSA and washed again. Images were obtained with a
laser scanning confocal microscope (LSM510; Carl Zeiss
Meditec, Jena, Germany) using a 63× oil objective or
with an inverted microscope (Ti-E; Nikon, Brussels,
Belgium) using 40× and 60× oil objectives.
Immunohistochemistry The Tph1-knockout (KO) mice
were obtained by knock-in of the lacZ gene and disruption
of Tph1 in embryonic stem cells as previously described
[28]. The Tph1-null mutation was backcrossed on to a
C57BL6/J background. Pancreases were dissected from
pregnant wild-type and Tph1-KO mice, and fixed in 4%
(wt/vol.) paraformaldehyde. Binding of primary serotonin
antibody (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) (ESM Table 2) was detected with biotinylated anti-
rat Ig in combination with streptavidin horseradish perox-
idase; diaminobenzidine was used as substrate (Dako,
Glostrup, Denmark). See also ESM Methods.
Insulin/serotonin release and content To determine seroto-
nin content, MIN6 cells and islets were homogenised in
serotonin buffer (0.01 mol/l HCl, 1 mmol/l EDTA,
4 mmol/l sodium metabisulfite) by 3 min sonication. Other
tissues were homogenised by douncing. After centrifugation
(20,000 g) for 15 min at 4°C and addition of 0.1% (wt/vol.)
ascorbic acid, lysates were stored at −20°C.
Diabetologia (2010) 53:2589–2599 2591Freshly isolated islets from P15.5 pregnant female mice
were incubated for 1 h in batches of 50 at 37°C. Incubation
was in Krebs HEPES buffer (20 mmol/l HEPES, pH7.4;
119 mmol/l NaCl; 4.75 mmol/l KCl; 2.5 mmol/l CaCl2;
1.2mmol/lMgSO4; 1.2 mmol/l KH2PO4; 5 mmol/l NaHCO3,
0.5% [wt/vol.] BSA) containing either 5 or 20 mmol/
l glucose. After 1 h, medium was removed and stored at
−20°C for measurement of insulin and serotonin release.
After 24 h incubation with PL, MIN6 cells were pre-
incubated for 1 h in Earl’s HEPES buffer (0.5% [wt/vol.]
BSA; 124 mmol/lNaCl; 5.3 mmol/lKCl;0.8mmol/l MgSO4;
1 mmol/l NaH2PO4; 10 mmol/l HEPES; 1.8 mmol/l CaCl2;
14.3 mmol/l NaHCO3; pH 7.35) containing 2 mmol/l glu-
cose, 10 μmol/l clorgyline (Sigma-Aldrich), a monoamine
oxidase A inhibitor and 0.1% (wt/vol.) ascorbic acid. Next,
cells were incubated in 2 or 20 mmol/l glucose. After
1 h, medium was recovered for quantification of insulin
and serotonin release using commercial ELISA kits
(LDN, Nordhorn, Germany; Mercodia, Uppsala, Sweden,
respectively).
Statistics All data are expressed as mean ± SEM, except the
microarray analysis where data are mean ± SD. Statistical
analysis was performed on experiments with n≥3 animals/
samples. Statistical significance was determined by a two-
tailed Student’s t test or Welch’s t test, except for the
monolayer experiments, where a Z test with value 1 (value
of control sample) was used.
Results
Induction of the two TPH isoforms in islets during preg-
nancy Ex vivo mRNA expression analysis of islets isolated
from non-pregnant mice vs mice at P15.5, revealed that one
of the most highly induced genes in islets during pregnancy
is Tph1 (MOE430_2.0 microarrays), which encodes the
rate-limiting enzyme of serotonin biosynthesis, TPH1
(ESM Fig. 1b), confirming a recent analysis [7]. The strong
upregulation was also observed by quantitative RT-PCR
(Fig. 1a) and at the protein level (Fig. 1c). With the
exception of a modest increase in the small intestine, Tph1
mRNA was not induced in any other tested tissue during
pregnancy (Fig. 1a). At variance with currently accepted
thinking that expression of the two non-allelic Tph genes is
divided between neuronal and non-neuronal cells [9, 16,
18], we found that Tph1 and Tph2 were strongly induced in
islets from pregnant females (Fig. 1b, ESM Fig. 1c). Even
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Fig. 1 Co-expression of Tph1 and Tph2 in islets of pregnant mice.
Quantitative RT-PCR analysis of mRNA encoding Tph1 (a) and Tph2
(b) in islets and in tissue as indicated from non-pregnant (white bars)
and P15.5 females (black bars). Results are mean ± SEM of three to
seven independent experiments (see also ESM Fig. 1). c Representa-
tive western blot of TPH1 protein levels in islets isolated from non-
pregnant (NP) and P15.5 mice. β-Actin was used as control for protein
load. Microarray analysis (Affymetrix MOE430_2.0) of mRNA
encoding Tph1 (d)a n dTph2 (e) in islets of non-pregnant (NP)
female mice, FACS-purified beta cells (male mice) and other tissues
as indicated. Primary beta cells expressed more Tph2 and less Tph1
than the MIN6 cell line. Brain and small intestine were used as
controls. *p<0.05, **p<0.01 and ***p<0.001 for difference be-
tween tested conditions
2592 Diabetologia (2010) 53:2589–2599under non-pregnant conditions, low expression of Tph1 and
Tph2 mRNAwas detectable in beta cells. Indeed, Tph2 was
more highly expressed in primary beta cells than in
tumoural MIN6 cells, whereas Tph1 mRNA was more
abundant in MIN6 cells (Fig. 1d, e). We further analysed
the expression of both genes in islets using a time course
analysis and MoGene_1.0_ST array to cover the 2nd and
3rd week of pregnancy, as well as mice 10 days postpartum.
As shown in Fig. 2a, expression of Tph1 in islets increased
markedly during the 2nd week of pregnancy, peaking
around P12.5 to P15.5, after which Tph1 mRNA decreased
again. However, Tph2 (Fig. 2b) reached a plateau at P9.5,
b
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Fig. 2 Time course of islet Tph1 and Tph2 mRNA expression and
serotonin content during pregnancy. Expression of Tph1 (a) and Tph2
mRNA (b) in islets isolated from non-pregnant (NP) mice, pregnant
mice on different days of pregnancy as indicated and mice at 10 days
postpartum (10 dpp). Expression was determined with the
MoGene_1.0_ST array. Values are mean ± SD, n=3–4. Tph1 mRNA
expression peaked around P12.5 to P15.5, whereas that of Tph2
plateaued from P9.5 onwards. Expression of both declined after
delivery. See ESM Fig. 2a for Tph1 expression in intestine at different
time points during pregnancy. c Time course of serotonin content in
islets isolated from mice as indicated (n=2–11). For the content of
different parts of the intestine, see ESM Fig. 3. a–c *p<0.05, **p<
0.01 and ***p<0.001 for difference between non-pregnant and
pregnant, or between indicated conditions. d Correlation analysis
between islet Tph1 or (e) Tph2 mRNA expression and serotonin
content. The correlation between Tph1 (r=0.951) and serotonin was
better than that between Tph2 (r=0.812) and serotonin. f Serotonin
immunostaining (brown) of pancreatic sections from pregnant mice.
Serotonin was used as blocking agent. Only a subset of the islet cells
was stained with an intensity similar to the time-dependent ELISA
measurement of serotonin content of isolated islets (c). No immunos-
taining was detected in Tph1-KO mice
Diabetologia (2010) 53:2589–2599 2593which lasted until P18.5. The characteristic time course of
Tph1 expression in islets was confirmed by quantitative
RT-PCR (ESM Fig. 2a) and could be clearly separated
from its rather constant expression in duodenum and
jejunum (ESM Fig. 2a). In addition to the tryptophan
hydroxylases, Ddc, the gene encoding the enzyme that
catalyses the final step of serotonin synthesis, was also
significantly upregulated during pregnancy (ESM Fig. 1d,
ESM Fig. 2b). Therefore, expression of all genes encoding
the enzymes involved in serotonin biosynthesis was found
to be strongly induced in islets from pregnant mice. In
contrast, mRNA encoding the enzymes needed for
conversion of serotonin into melatonin was so low as to
be undetectable (data not shown).
Increased serotonin content in islets during pregnancy To
assess the functional consequence of these mRNA changes,
we measured serotonin content in islets isolated from
pregnant and non-pregnant female mice (Fig. 2c). The
basal serotonin content in islets from non-pregnant mice
was close to the lower detection threshold (0.004 pmol/
islet). During pregnancy, however, islet serotonin content
increased ∼200-fold (Fig. 2c), with a time course very
similar to that of Tph1 expression (r=0.951) (Fig. 2d), but
less so to that of Tph2 expression (r=0.812) (Fig. 2e).
Immunhistochemistry confirmed this temporal profile of
serotonin content during pregnancy (Fig. 2f). In contrast,
the small changes during pregnancy in intestinal Tph1
expression (ESM Fig. 2a) were not associated with changes
in serotonin content (ESM Fig. 3).
Placental lactogens induce Tph1 and Tph2 expression in
islets during pregnancy Because traces of Tph1 and Tph2
expression can be found in beta cells under non-pregnant
conditions, we next investigated which factor during
pregnancy is responsible for the strong upregulation of
Tph1 and Tph2 mRNA. As lactogens have a crucial role in
other pregnancy-related changes in islets [2, 3], we
analysed the role of PL. We first confirmed that PRLRs
are abundantly expressed in both systems, finding in
addition that their mRNA levels further increased during
pregnancy (ESM Fig. 4a), which is consistent with the
literature [29]. Next, we observed that PL increased Tph1
mRNA expression in MIN6 cells in a concentration-
dependent manner (Fig. 3a). Tph2 mRNA expression
was also increased by 500 ng/ml PL (Fig. 3b). The
induction of TPH1 by PL was further confirmed at the
protein level via western blotting (Fig. 3c). Next, we
checked that the effect of PL on MIN6 cells was also seen
in cultured islets isolated from non-pregnant mice and
stimulated for 24 h with 500 ng/ml PL. As seen in Fig. 3d, e,
this treatment also induced expression of Tph1 and Tph2 in
islets.
Placental lactogens activate the JAK2–STAT5 pathway to
enhance Tph1 expression Lactogen-stimulated PRLRs can
alter beta cell function via three different signalling
pathways: (1) JAK2–STAT5 (2) RAS–RAF–MAPK; and
(3) PI3K [4. 5]. To determine whether any of these
pathways mediated the strong induction of Tph1 mRNA
as observed in vivo and in vitro, we tested the effect of
specific pharmacological inhibitors for each of these
pathways, using as readouts quantitative RT-PCR for
RNA signal and western blotting for protein signal
(Fig. 3f–h). Several observations were made. First, only
the JAK2–STAT5 pathway was convincingly activated
after PL treatment. Second, neither the PI3K inhibitor,
wortmannin, nor the MEK1/2-inhibitor-1 significantly
downregulated Tph1 expression in PL-treated MIN6 cells
(Fig. 3g, h). Finally, the JAK2 inhibitor, tyrphostin
AG490, almost completely abolished the influence of PL
on Tph1 mRNA and protein levels (Fig. 3f). Next, we
overexpressed mRNA encoding the dominant active forms
of STAT5A and STAT5B (STAT5A1*6 and STAT5B1*6
respectively) in MIN6 cells. Overproduction of these
dominant active forms led to a significant increase in
Tph1 mRNA expression (ESM Fig. 4b). Overproduction
of a dominant negative STAT5 (STAT5AΔ749) counter-
acted the effect of PL on Tph1 expression (ESM Fig. 4c).
Also two putative Stat consensus binding sequences,
consistent with the known interferon gamma-activated
sequence (consensus, TTCNNNGAA) [30], have been
found in Tph1 and Tph2 gene promoters by searching
NCBI (accession numbers mus musculus Tph1 and Tph2
genes: U96811 and NC_000076.5 respectively; www.ncbi.
nlm.nih.gov/guide/, accessed 8 July 2010). These data
show that during pregnancy, lactogens play an important
role in the induction of Tph1 and Tph2 in beta cells via
PRLR–JAK2–STAT5 signalling.
Different kinetics of insulin and serotonin release in beta
cells Pregnancy is known to enhance functional beta cell
mass [2, 31]. In agreement with this idea, islet insulin
content and glucose-induced insulin release increased in
pregnant mice (ESM Fig. 5a, b). The time course of
insulin content per islet differed from that of islet
serotonin content, which declined during the last week of
pregnancy and during lactation (Fig. 2c). Next, we
investigated whether the stored islet serotonin could be
released from islets isolated from P15.5 mice. Insulin and
serotonin release were measured after 1 h of incubation in
the presence of low (5 mmol/l) and high (20 mmol/l)
glucose levels. The basal rate of serotonin release was
high compared with that of insulin, making up 16±6% of
total islet serotonin content per h vs 1.5±0.7% of total islet
insulin content per h (Fig. 4a). A second difference
between insulin and serotonin release was found in the
2594 Diabetologia (2010) 53:2589–2599degree of glucose stimulation. Thus 20 mmol/l glucose
increased insulin release fivefold, but enhanced serotonin
release only twofold (Fig. 4a). Similar observations were
made with PL-stimulated MIN6 cells (Fig. 4b). Insulin
and serotonin content of pregnant islets and MIN6 cells
were not influenced by the glucose concentration (ESM
Fig. 5c, d). Together, our data indicate that insulin and
serotonin release can be at least partially dissociated, both
in terms of basal fractional turnover and glucose stimula-
tion. In support of this idea, insulin and serotonin
immunostaining did not overlap in PL-treated MIN6 cells
(Fig. 4c), suggesting that different granule pools are
involved.
Serotonin is produced by a subpopulation of beta cells TPH1
and serotonin could be detected in the same cells,
supporting the important role of this isoform in serotonin
production of MIN6 cells (Fig. 5a). Interestingly, only a
subpopulation of PL-stimulated MIN6 cells had built up a
detectable serotonin pool (Fig. 5b). We also observed that
with increasing PL concentrations, the number of
serotonin-containing cells increased to reach a plateau of
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Fig. 3 Placental lactogens induce Tph1 and Tph2 expression in
cultured beta cells. Tph1 mRNA (a) was induced in MIN6 cells by
ovine PL (oPL) in a concentration-dependent manner. Effect, in MIN6
cells, of 500 ng/ml oPL (24 h) on Tph2 mRNA (b) and TPH1 protein
(c); the immunoblot in c is representative of three independent
experiments. Quantitative RT-PCR data are mean ± SEM, n=3. Effect
of 24 h 500 ng/ml oPL on Tph1 mRNA (d) and Tph2 mRNA (e)i n
islets cultured as monolayers after isolation from non-pregnant mice.
MIN6 cells incubated with oPL were treated with specific inhibitors of
three signalling pathways, namely tyrphostin AG490 (50 μmol/l) for
JAK2–STAT5 (f), MEK1/2-inhibitor-1 (10 μmol/l) for RAS–RAF–
MAPK (g) and wortmannin (100 nmol/l) for PI3K (h). Tph1
expression was quantified via quantitative RT-PCR (mean ± SEM,
n=3–4) and TPH1 protein via western blotting (blots are representative
of three to four experiments). The JAK2 inhibitor tyrphostin AG490
reduced Tph1 expression in MIN6 cells treated with oPL. For
expression of Prlr mRNA in islets during pregnancy, see ESM
Fig. 4.* p<0.05, **p<0.01 and ***p<0.001 for difference between
non-treated controls and treated conditions, as analysed by Student’s t
test (MIN6 cells) and Z test (islets cultured in monolayers)
Diabetologia (2010) 53:2589–2599 2595approximately 25% at 100 ng/ml (Fig. 5c,E S MF i g .6).
Immunostaining experiments on PL-stimulated islets
showed strong beta cell heterogeneity in TPH1 protein
and cellular serotonin accumulation (Fig. 5d). No
glucagon-positive cells were seen to have accumulated
serotonin. This heterogeneity is consistent with and
confirms the heterogenic pattern of serotonin staining of
pancreatic sections from pregnant mice (Fig. 2f).
Low serotonin receptor expression in islets of pregnant and
non-pregnant mice A local effect of serotonin on beta cell
function (insulin production, release, beta cell replication)
is expected to depend on expression of one of the 14
serotonin receptors in islets. However, as illustrated in ESM
Fig. 7, we were unable to detect a real signal for these
receptors in islets, either with MOE430_2.0 arrays (ESM
Fig. 7a) or with MoGene_1.0_ST arrays (ESM Fig. 7b–o),
whereas brain tissue gave clear signals for several receptors.
Furthermore, none of the serotonin receptors increased
significantly (p<0.001, fold change ≥1.5) during pregnan-
cy. We next performed quantitative RT-PCR analysis for
Htr1d and Htr2b; however, expression of these was below
the detection limit (data not shown). Together, we observed
that the very low receptor expression did not parallel the
strong induction of the serotonin biosynthetic pathway.
Discussion
In this paper we provide evidence for a strong upregulation
of serotonin production in a subpopulation of mouse beta
cells during pregnancy, an upregulation which is dependent
on lactogens. In this physiogical condition, Tph1 in
particular was dramatically induced, resulting in an accu-
mulation of serotonin in beta cells and subsequent rapid
secretion of the synthesised serotonin. During in vitro
release experiments, we showed that the fractional turnover
time of newly synthesised and stored serotonin is in the
range of a few hours, i.e. ten times smaller than that of
insulin [32, 33].
It is widely agreed today that the serotonin system in
mammals is subdivided into cell types that synthesise
serotonin via TPH1 (non-neuronal cells) or TPH2 (neuronal
cells) [8, 9, 16–18]. Beta cells do not follow this
subdivision, as we observed induction of both genes,
Tph1 and Tph2. This duality is intriguing because on the
one hand pancreatic beta cells and enterochromaffin cells
seem to be derived from a common developmental
precursor cell in the endoderm [34], and on the other hand
adult differentiated beta cells share many phenotypic traits
with neurons, a fact explained by the common avoidance of
repressor element 1-silencing transcription factor produc-
tion [35, 36]. One aspect of this “neuron-like” behaviour is
that adult beta cells produce several enzymes for neuro-
transmitter synthesis, e.g. tyrosine hydroxylase [37], dopa
decarboxylase [19] and glutamate decarboxylase [38]. Beta
cells, moreover, store and secrete γ-aminobutyric acid
(GABA) and possibly other amines via synaptic-like
microvesicles [39]. The current observations extend this
neuronal phenotype by showing that beta cells express
Tph2 and store serotonin in a compartment that does not
overlap with insulin. The stronger correlation between islet
serotonin content and Tph1 mRNA expression vs islet
serotonin and Tph2 mRNA expression may, however,
indicate that, of the two isoenzymes, Tph1 contributes most
to serotonin biosynthesis in islets. This idea is supported by
immunohistochemistry of pancreatic sections of pregnant
Tph1-KO, as no serotonin staining was detected in the islets
(Fig. 2f).
A parallel finding between this study and previous
analysis of GABA synthesis and release [40] is that the
fractional release rates of GABA and serotonin largely
exceed those of insulin by one order of magnitude. At one
level, this difference could be explained by the fact that
release rates of GABA [40]a n ds e r o t o n i nd e p e n do n
enzymatic biosynthetic flux, which is governed by levels
of flux-controlling enzymes, whereas insulin release is
primarily controlled at the level of exocytosis. At another
level, the explanation could be the existence of non-
overlapping storage pools of insulin and serotonin,
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Fig. 4 Dissociated release of serotonin and insulin from pregnant
islets and PL-stimulated MIN6 cells. a Insulin (white bars) and
serotonin (black bars) release, expressed as per cent of total content
per h from pancreatic islets freshly isolated from P15.5 females,
showed a different pattern (for details on content, see ESM Fig. 5c).
Release and content were measured after 1 h incubation in 5 or
20 mmol/l glucose. b Similar results were obtained for insulin and
serotonin release of ovine PL-treated MIN6 cells incubated for 1 h in 2
or 20 mmol/l glucose (for details on content, see ESM Fig. 5d). The
change in insulin content during pregnancy is shown in ESM Fig. 5a;
insulin release from islets isolated from non-pregnant vs pregnant
mice is shown in ESM Fig. 5b. Values (a, b) are mean ± SEM; n=4.
*p<0.05 and **p<0.01 for differences between indicated conditions.
c Non-overlapping serotonin and insulin immunostaining in the same
MIN6-cell. Two representative microscopic images of MIN6 cells
treated for 24 h with 500 ng/ml ovine PL after double immunostaining
for serotonin (red) and insulin (green). Cell nuclei were stained with
Hoechst (blue)
2596 Diabetologia (2010) 53:2589–2599suggesting that serotonin is not stored in dense-core
granules, but rather in synaptic-like microvesicles, as
proposed for GABA [39]. However, when serotonin or
its precursor 5-hydroxytryptophan are added to the
medium, it is stored together with insulin in dense-
core granules [41]. In contrast to GABA production, the
synthesis and storage of serotonin only occurs at
detectable rates during pregnancy, a process which
seems to be critically dependent on PL-stimulation of
PRLRs and activation of the JAK2–STAT5 pathway.
According to our observations, this process is also
restricted to a subset of the beta cell population. Rodent
beta cells are known to be functionally heterogeneous in
glucose-induced insulin biosynthesis and release [42–
44]. Precisely why Tph1 is strongly induced in a
subpopulation of beta cells needs to be further studied.
One explanation is that this induction only occurs in newly
divided beta cells or in cells that are preparing for
replication. Alternatively, serotonin biosynthesis may be
restricted anatomically to sites in the islet that sustain
increased islet function, considering the fact that serotonin
is a powerful vasoconstrictor.
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Fig. 5 A subpopulation of PL-stimulated beta cells was induced to
produce serotonin. a Confocal microscopy of MIN6 cells treated for
24 h with 500 ng/ml ovine PL (oPL). Double immunostaining for
TPH1 (green) and serotonin (red). Nuclei were stained with Hoechst
(blue). Immunoreactive TPH1 and serotonin are present in the same
cell. b Presence of serotonin (red) in a subset of PL-stimulated
insulin-containing MIN6 cells (insulin, green). c Per cent of
serotonin-positive MIN6 cells after treatment with different concen-
trations of oPL for 24 h; values mean ± SEM, n=3 except for 100 ng/
ml where n=2; counting done blind by three independent persons. *p
<0.05 and ***p<0.001 for difference between non-treated controls
and treated conditions. d Confocal microscopy of islets treated for
24 h with 500 ng/ml oPL, showing overlays of immunoreactivity for
TPH1 (green) and serotonin (red), insulin (green) and serotonin (red),
and glucagon (green) and serotonin (red). Data indicate that a
subpopulation of primary islet beta cells contains serotonin after
stimulation with PL
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serotonin production that we observed? Although it has been
known for decades that islets of some species are serotonin-
rich in the non-pregnant condition [45] and pancreatic beta
cells can take up exogenous serotonin [46], the role of this
amine in beta cell physiology remains poorly understood.
Paulman et al. recently described receptor-independent
serotonylation of Rab proteins in beta cells [22], indicating
that serotonin generates an autocrine signal for enhanced
beta cell function. However, we were unable to detect any
serotonylation via ELISA when MIN6 cells were treated
with PL for 24 h (data not shown; see also, ESM Methods).
A second role of serotonin might be the stimulation of
beta cell proliferation. TPH1-dependent serotonin produc-
tion sustains replication of hepatocytes in the regenerating
liver [14] and regulates bone mass [13]. One argument
against a triggering role of pregnancy-induced serotonin in
the control of beta cell proliferation is the time course. In
the accompanying manuscript in this issue of Diabetologia
[47], we show that the peak of cell cycle gene expression
occurs at P9.5, which cannot be explained by Tph1
expression and serotonin production. But perhaps serotonin
could have a permissive role at a later regulatory step? Not
consistent with this idea is the fact that we found no
difference in the amount of proliferating beta cells between
wild-type and Tph1-KO mice during pregnancy, although
no serotonin could be detected in the KO mice (ESM
Fig. 8, ESM Methods). Therefore, it seems unlikely that
Tph1 induction in islets of pregnant mice plays a major role
in beta cell proliferation during pregnancy.
A third possibility is that the secreted serotonin plays a
systemic role. Our inability to detect islet serotonin receptor
mRNA expression above background signal and failure to
measure an upregulation of any of these receptors during
pregnancy (ESM Fig. 7) may support this possibility.
Studies with Tph1-KO mice have shown that maternal
serotonin production is important for normal brain and
heart development of the fetus [17, 28, 48]. The induction
of Tph1 in beta cells during the 2nd week of pregnancy and
the decline of its expression after P15.5 is compatible with
a time window in which fetal cells are receptive to
serotonin but cannot yet produce the monoamine them-
selves. A broader link between serotonin and mammalian
female reproduction has already been established. Thus
serotonin biosynthesis is upregulated in mammary glands
during pregnancy and plays a local negative feedback on
milk synthesis [11, 49, 50]. To check this third possibility,
further investigations are required.
Finally, serotonin can be converted to melatonin via a
two-step pathway [15]. However, arylalkylamine N-
acetyltransferase, the enzyme of the first step, is not
i n d u c e di ni s l e t sd u r i n gp r e g n a n c ya n de x p r e s s i o no fi ti s
also very low in non-pregnant islets (data not shown).
Taken together with the fact that there is a natural
melatonin ‘knockdown’ in C57BL6/J mice [51]w e
propose that serotonin is not metabolised to melatonin in
islets during pregnancy.
In summary, we have shown that a spectacular rise of
serotonin production occursi ni s l e t sd u r i n gp r e g n a n c y
and that this process occurs via PL stimulation of the
JAK2–STAT5 pathway in a subpopulation of beta cells.
The functional role of this newly identified source of
serotonin constitutes an important issue to be studied in
further detail.
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